M. Brigida

University of Rome Tor Vergata

Health Outcomes Studied

• Reduced Abdominal Pain

Papers (2)

• 2022
  Randomized control trial on the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in reducing inflammatory markers in acute uncomplicated diverticulitis10.1097/MEG.0000000000002342
• 2021
  Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?10.3390/medicina57070643